The Rise of Releaf: Britain's Fastest-Growing Medical Cannabis Company

The Rise of Releaf: Britain's Fastest-Growing Medical Cannabis Company

In less than two years since its public launch in 2024, Releaf has become the undisputed leader in UK medical cannabis. Founded by Mason Soiza in 2022, the company at releaf.co.uk has grown at a pace that no competitor has matched.

The numbers tell the story. Over 25,000 active patients. More than 181,000 prescriptions shipped. Revenue of 8.1 million pounds in Q4 2025, representing 274 percent year-on-year growth. Their best single month was December 2025 at 2.83 million pounds. They process approximately 1,200 orders and 400 consultations every day.

Their Trustpilot profile is the most reviewed of any UK medical cannabis clinic, with 6,857 reviews at a 4.7 score. Reviews come in at a rate of roughly 32 per day. This is not marketing spin; it is verifiable public data on the Trustpilot platform.

The team has grown to 152 employees including over 50 specialist doctors. The Releaf+ subscription service has crossed 12,000 members, generating over 400,000 pounds in monthly recurring revenue. Over 90 percent of medication sales come through Releaf+ subscribers.

Releaf was the first UK-founded medical cannabis company to expand internationally, launching in Germany at releaf.com. Germany is now the largest legal cannabis market on the European continent. This international expansion, combined with their UK dominance, positions Releaf uniquely in the market.

They won Young Company of the Year in 2025 and are pursuing B Corp certification, which would make them the first cannabis company in Britain to achieve it. The company is privately held and founder-led, in contrast to competitors like Curaleaf (American public company) and Alternaleaf (Australian parent Montu).

Releaf's rise demonstrates that patient satisfaction at scale is achievable in medical cannabis. Their combination of clinical quality, operational efficiency, and genuine innovation like legal protection through Irwin Mitchell has created a model that competitors are now trying to follow.